Companies: 10,305     total market cap: NZ$199.600 T
🇩🇪 Deutsch🇫🇷 Français
$USD🇺🇸€EUR🇪🇺₹INR🇮🇳£GBP🇬🇧$CAD🇨🇦$AUD🇦🇺$HKD🇭🇰$SGD🇸🇬
Repligen
RGEN
#1963
Rank
NZ$14.34 B
Marketcap
🇺🇸 United States
Country
$255.95
Share price
-1.42%
Change (1 day)
-11.52%
Change (1 year)
🧬 Biotech
Categories

Earnings for Repligen (RGEN)

Earnings in 2024 (TTM): NZ$32.05 Million

According to Repligen 's latest financial reports the company's current earnings are NZ$0.62 Billion. In 2023 the company made an earning of NZ$85.84 Million a decrease over its 2022 earnings that were of NZ$0.39 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Repligen from 1985 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) NZ$32.05 M-62.66%
2023 NZ$85.84 M-78.01%
2022 NZ$0.39 B33.37%
2021 NZ$0.29 B131.52%
2020 NZ$0.12 B101.31%
2019 NZ$62.79 M25.93%
2018 NZ$49.86 M105.61%
2017 NZ$24.25 M-11.46%
2016 NZ$27.39 M14.91%
2015 NZ$23.83 M20.26%
2014 NZ$19.82 M-51.49%
2013 NZ$40.86 M90.98%
2012 NZ$21.39 M
2010 NZ$0.31 M-103.81%
2009 -NZ$8.13 Million-223.84%
2008 NZ$6.56 M
2006 -NZ$4.41 Million229.64%
2005 -NZ$1.34 Million-89.16%
2004 -NZ$12.35 Million-16.86%
2003 -NZ$14.85 Million88.72%
2002 -NZ$7.87 Million-27.88%
2001 -NZ$10.91 Million-1.74%
2000 -NZ$11.1 Million85.93%
1999 -NZ$5.97 Million159.16%
1998 -NZ$2.31 Million85.71%
1997 -NZ$1.25 Million-70.83%
1996 -NZ$4.26 Million-72.41%
1995 -NZ$15.42 Million-60.63%
1994 -NZ$39.16 Million45.39%
1993 -NZ$26.94 Million39.45%
1992 -NZ$19.32 Million-32.3%
1991 -NZ$28.53 Million6.62%
1990 -NZ$26.76 Million1577.78%
1989 -NZ$1.6 Million-57.14%
1988 -NZ$3.73 Million-362.5%
1987 NZ$1.41 M-130.77%
1986 -NZ$4.61 Million136.36%
1985 -NZ$1.95 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novavax
NVAX
-NZ$0.47 Billion-1,468.82%🇺🇸 USA
BioMarin Pharmaceutical
BMRN
NZ$0.69 B 1,936.37%🇺🇸 USA
Neurocrine Biosciences
NBIX
NZ$1.16 B 3,316.22%🇺🇸 USA
General Electric
GE
NZ$14.68 B 43,015.02%🇺🇸 USA
Thermo Fisher Scientific
TMO
NZ$12.11 B 35,461.57%🇺🇸 USA
Bristol-Myers Squibb
BMY
-NZ$12.19 Billion-35,890.46%🇺🇸 USA
Pfizer
PFE
NZ$12.30 B 36,018.19%🇺🇸 USA
Bio-Techne
TECH
NZ$0.33 B 884.87%🇺🇸 USA
Sangamo Therapeutics
SGMO
-NZ$0.24 Billion-798.23%🇺🇸 USA
Charles River Laboratories
CRL
NZ$0.91 B 2,597.87%🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2024 CompaniesMarketcap.com